Glucagon-like peptide-1 receptor agonists (GLP-1RAs) such as semaglutide, liraglutide, and tirzepatide are widely prescribed ...

A new study reveals that diabetes and weight loss drugs known as GLP-1s are lined with an increased risk of a chronic ...

"WHO backs use of GLP-1RAs for weight loss despite shortage warning" was originally created and published by Pharmaceutical ...

Researchers determine the risk of pregnancy weight gain in patients who were prescribed GLP-1 RAs prior to conception.

Semaglutide shows potential for weight loss in older adults without harming bone density, but longer studies are essential to ...

Oral semaglutide did not significantly reduce disease progression in patients with early Alzheimer disease, according to results from two phase 3 trials.

The authors conclude that early use of semaglutide may serve as an effective adjunctive strategy to mitigate the metabolic burden associated with SGAs. By intervening during the initial stages of ...

GLP-1RAs and DPP-4is are associated with a higher risk for biliary disease than SGLT2is among individuals with type 2 diabetes.

RA orforglipron provides superior weight loss and cardiometabolic improvement vs placebo for adults with T2D and obesity.

Welcome to Culture Clinic, MedPage Today's collaboration with Northwell Health to offer a healthcare professional's take on the latest viral medical topics. Doctors performing certain medical scans on ...